New shot aims to keep blood pressure down after hospital discharge
NCT ID NCT07511361
First seen Apr 11, 2026 · Last updated Apr 26, 2026 · Updated 2 times
Summary
This study tests an investigational drug called tonlamarsen in 100 adults who were recently hospitalized for dangerously high blood pressure. The goal is to see if the drug can safely lower blood pressure and reduce a protein linked to hypertension. Participants will receive either tonlamarsen or a placebo and be monitored for 12 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Progressive Medical Research
Port Orange, Florida, 32127, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.